AIMS/HYPOTHESIS: Toll-like receptor 4 (TLR4) is a receptor for saturated fatty acids (SFAs), global deficiency of which has been shown to protect against inflammation, insulin resistance and atherosclerotic lesion formation. Because macrophages express Tlr4 and are important in insulin resistance and atherosclerotic lesion formation due to their infiltration of white adipose tissue (WAT) and the artery wall, respectively, we hypothesised that deficiency of macrophage TLR4 could protect against these disorders. METHODS: Bone marrow transplantation of agouti, LDL-receptor deficient (A(y)/a; Ldlr (-/-)) mice with marrow from either C57BL/6 or Tlr4 (-/-) mice was performed. Recipient mice with Tlr4 (+/+) marrow (MthetaTLR4(+/+)) or with Tlr4 (-/-) marrow (MthetaTLR4(-/-)) were then placed on one of four diets: (1) low fat; (2) high fat; (3) high fat rich in SFAs (HF(SFA)); and (4) HF(SFA) supplemented with fish oil. RESULTS: There were no differences in body composition or plasma lipids between MthetaTLR4(+/+) and MthetaTLR4(-/-) mice on any of the diets. However, we observed a decrease in some macrophage and inflammatory markers in WAT of female low fat-fed MthetaTLR4(-/-) mice compared with MthetaTLR4(+/+) mice. MthetaTLR4(-/-) mice fed low-fat diet also displayed decreased atherosclerotic lesion area. There were no differences in macrophage accrual in WAT or atherosclerosis between MthetaTLR4(+/+) and MthetaTLR4(-/-) mice fed any of the high-fat diets. Finally, no difference was seen in insulin sensitivity between MthetaTLR4(+/+) and MthetaTLR4(-/-) mice fed the HF(SFA) diet. CONCLUSIONS/ INTERPRETATION: These data suggest that under certain dietary conditions, macrophage expression of Tlr4 can be an important mediator of macrophage accumulation in WAT and the artery wall.
AIMS/HYPOTHESIS: Toll-like receptor 4 (TLR4) is a receptor for saturated fatty acids (SFAs), global deficiency of which has been shown to protect against inflammation, insulin resistance and atherosclerotic lesion formation. Because macrophages express Tlr4 and are important in insulin resistance and atherosclerotic lesion formation due to their infiltration of white adipose tissue (WAT) and the artery wall, respectively, we hypothesised that deficiency of macrophage TLR4 could protect against these disorders. METHODS: Bone marrow transplantation of agouti, LDL-receptor deficient (A(y)/a; Ldlr (-/-)) mice with marrow from either C57BL/6 or Tlr4 (-/-) mice was performed. Recipient mice with Tlr4 (+/+) marrow (MthetaTLR4(+/+)) or with Tlr4 (-/-) marrow (MthetaTLR4(-/-)) were then placed on one of four diets: (1) low fat; (2) high fat; (3) high fat rich in SFAs (HF(SFA)); and (4) HF(SFA) supplemented with fish oil. RESULTS: There were no differences in body composition or plasma lipids between MthetaTLR4(+/+) and MthetaTLR4(-/-) mice on any of the diets. However, we observed a decrease in some macrophage and inflammatory markers in WAT of female low fat-fed MthetaTLR4(-/-) mice compared with MthetaTLR4(+/+) mice. MthetaTLR4(-/-) mice fed low-fat diet also displayed decreased atherosclerotic lesion area. There were no differences in macrophage accrual in WAT or atherosclerosis between MthetaTLR4(+/+) and MthetaTLR4(-/-) mice fed any of the high-fat diets. Finally, no difference was seen in insulin sensitivity between MthetaTLR4(+/+) and MthetaTLR4(-/-) mice fed the HF(SFA) diet. CONCLUSIONS/ INTERPRETATION: These data suggest that under certain dietary conditions, macrophage expression of Tlr4 can be an important mediator of macrophage accumulation in WAT and the artery wall.
Authors: N C Arbour; E Lorenz; B C Schutte; J Zabner; J N Kline; M Jones; K Frees; J L Watt; D A Schwartz Journal: Nat Genet Date: 2000-06 Impact factor: 38.330
Authors: Savitha Subramanian; Chang Yeop Han; Tsuyoshi Chiba; Timothy S McMillen; Shari A Wang; Antonio Haw; Elizabeth A Kirk; Kevin D O'Brien; Alan Chait Journal: Arterioscler Thromb Vasc Biol Date: 2008-01-31 Impact factor: 8.311
Authors: Jeremy E Davis; Nicholas K Gabler; Jennifer Walker-Daniels; Michael E Spurlock Journal: Obesity (Silver Spring) Date: 2008-04-10 Impact factor: 5.002
Authors: Daniela M L Tsukumo; Marco A Carvalho-Filho; José B C Carvalheira; Patrícia O Prada; Sandro M Hirabara; André A Schenka; Eliana P Araújo; José Vassallo; Rui Curi; Lício A Velloso; Mario J A Saad Journal: Diabetes Date: 2007-05-22 Impact factor: 9.461
Authors: Viswanathan Saraswathi; Ling Gao; Jason D Morrow; Alan Chait; Kevin D Niswender; Alyssa H Hasty Journal: J Nutr Date: 2007-07 Impact factor: 4.798
Authors: M Poggi; D Bastelica; P Gual; M A Iglesias; T Gremeaux; C Knauf; F Peiretti; M Verdier; I Juhan-Vague; J F Tanti; R Burcelin; M C Alessi Journal: Diabetologia Date: 2007-04-11 Impact factor: 10.122
Authors: Laura B Buckman; Alyssa H Hasty; David K Flaherty; Christopher T Buckman; Misty M Thompson; Brittany K Matlock; Kevin Weller; Kate L J Ellacott Journal: Brain Behav Immun Date: 2013-07-04 Impact factor: 7.217
Authors: Suzhao Li; Yu Sun; Chien-Ping Liang; Edward B Thorp; Seongah Han; Andreas W Jehle; Viswanathan Saraswathi; Brian Pridgen; Jenny E Kanter; Rong Li; Carrie L Welch; Alyssa H Hasty; Karin E Bornfeldt; Jan L Breslow; Ira Tabas; Alan R Tall Journal: Circ Res Date: 2009-10-15 Impact factor: 17.367
Authors: Daniel J Westcott; Jennifer B Delproposto; Lynn M Geletka; Tianyi Wang; Kanakadurga Singer; Alan R Saltiel; Carey N Lumeng Journal: J Exp Med Date: 2009-12-07 Impact factor: 14.307
Authors: Maziyar Saberi; Niels-Bjarne Woods; Carl de Luca; Simon Schenk; Juu Chin Lu; Gautam Bandyopadhyay; Inder M Verma; Jerrold M Olefsky Journal: Cell Metab Date: 2009-11 Impact factor: 27.287